002581SZSE

*ST Weiming Co., Ltd.

*ST未名

002581

Shenzhen Stock Exchange

Follow
31 announcements tracked· Last: May 21, 2026

Key Financials

As of 2026-05-23T00:00:00.000+00:00
Revenue¥43.9M
Net Profit-¥54.2M
ROE-3.01%
Debt Ratio8.89%
Monetary Funds¥153.9M
Receivables¥248.8M
Total Shares659.7M

Announcements

29 total

Announcement on Receiving Dividends from Associated Companies

Share Repurchase PlanShareholding Change DisclosureListed Company Announcements

Announcement on Participating in the 2026 Online Collective Reception Day for Investors of Listed Companies in Shandong Region

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Announcement on abnormal fluctuations in stock trading

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Announcement on Abnormal Stock Trading Volatility

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Announcement on the Application for Comprehensive Credit Limit from the Bank

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

2025 Q3 Report (Corrected)

Share Repurchase PlanShareholding Change DisclosurePeriodic Financial Reports

Explanation by the Board on the Correction of Prior Accounting Errors and Retrospective Adjustments

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Announcement on the Correction of Prior Accounting Errors and Retrospective Adjustments

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Reasonableness Explanation by the Audit Committee of the Board on the Correction of Prior Accounting Errors and Retrospective Adjustments

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

2025 Annual Independent Director Work Report (Cai Yanhong)

Convertible BondsShareholding Change DisclosureListed Company Announcements

2025 Annual Independent Director Work Report (Liu Yang) - Resigned

Convertible BondsShareholding Change DisclosureListed Company Announcements

2025 Annual Independent Director Work Report (Yang Jun)

Convertible BondsShareholding Change DisclosureListed Company Announcements

2025 Annual Independent Director Work Report (Xia Yang)

Convertible BondsShareholding Change DisclosureListed Company Announcements

2025 Annual Independent Director Work Report (Zhang Rongfu)

Convertible BondsShareholding Change DisclosureListed Company Announcements

2025 Annual Internal Control Audit Report of Shandong Weiming Biomedical Co., Ltd.

Share PledgeShareholding Change DisclosureListed Company Announcements

2025 Annual Internal Control Rules Implementation Self-Check Form

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

2025 Annual Internal Control Self-Evaluation Report

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Announcement on the Confirmation of 2025 Compensation for Directors and Senior Management and the 2026 Compensation Plan

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Compensation Management System for Directors and Senior Management

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Announcement on Changes in Accounting Policies

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Announcement on the Provision for Asset Impairment for 2025

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Reasonableness Explanation by the Audit Committee of the Board on the Provision for Asset Impairment for 2025

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Announcement on Providing Financial Assistance to the Controlling Subsidiary

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

2025 Annual Board Work Report

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Notice of the 2025 Annual Shareholders' Meeting

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Resolution Announcement of the 12th Meeting of the 6th Board of Directors

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Announcement on the Company's Profit Distribution Plan for 2025

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Q1 2026 Report

Share Repurchase CompletionShareholding Change DisclosurePeriodic Financial Reports

Special Explanation on the Non-Standard Audit Opinion on the 2025 Financial Statements of Shandong Weiming Biomedical Co., Ltd.

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Notes & Comments

Sign in to leave a comment or private note.

Loading…